Reduction in plasma total homocysteine through increasing folate intake in healthy individuals is not associated with changes in measures of antioxidant activity or oxidant damage

European Journal of Clinical Nutrition

Volumn 57, Issue 3, 2003, Pages 483-489

  Moat, S J ^a,b   Hill, M H ^a   McDowell, I F W ^b   Pullin, C H ^b   Ashfield Watt, P A L ^b   Clark, Z E ^b   Whiting, J M ^b   Newcombe, R G ^b   Lewis, M J ^b   Powers, H J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antioxidant activity; Cardiovascular disease; Folate; Homocysteine; Oxidant damage

Indexed keywords

FOLIC ACID; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADULT; AMINO ACID BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY INTAKE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PLASMA; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; NUTRITIONAL STATUS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; RISK FACTORS; SINGLE-BLIND METHOD; SUPEROXIDE DISMUTASE;

EID: 12244308479     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601554     Document Type: Article

References (43)

1. Andersson A, Isakson A, Brattstrom L & Hultberg B (1993): Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin. Chem. 39, 1590-1597.
2. Ashfield-Watt PAL, Pullin C, Whiting J, Clark ZE, Moat SJ, Burr ML, Lewis MJ, Powers HJ & McDowell IFW (2002): Methylene tetrahydrofolate reductase (C677T) genotype modulates blood folate and homocysteine responses to a folate rich diet or low dose folate supplement: a randomised controlled trial. Am. J. Clin. Nutr. 76, 180-186.
3. Bellamy MF & McDowell IFW (1997): Putative mechanisms for vascular damage by homocysteine. J. Inher. Metab. Dis. 20, 307-315.
4. Blom HJ, Kleinveld HA, Boers GHJ, Demacker PNM, Hak-Lemmers HLM, Te Poele-Pothoff MTWB & Trijbels JMF (1995): Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. Eur. J. Clin. Invest. 25, 149-154.
5. Blundell G, Goodman Jones B, Rose FA & Tudball N (1996): Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis 122, 163-172.
6. Bonham JR, Moat SJ, Bones CH, McDowell IFW, Lewis MJ & Powers HJ (2000): Oral ascorbic acid ameliorates homocysteine-mediated endothelial dysfunction in classical homocystinuria both acutely and chronically. J. Inher. Metab. Dis. 23(Suppl), 65.
7. Bostom AG, Rosenberg IH, Lindenmens J, Hofmasn A & Grobbee DE (1997): Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly. The Rotterdam Study. J. Intern. Med. 242, 339-347.
8. Boushey CJ, Beresford SA, Omenn GS & Motulsky AG (1995): A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274, 1049-1057.
9. Chambers JC, McGregor A, Jean-Marie J, Obeid OA & Kooner JS (1999): Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinaemia: an effect reversible with vitamin C therapy. Circulation 99, 1156-1160.
10. Clark ZE, Bowen DJ, Whately SD, Bellamy MF, Collins PW & McDowell IFW (1998): Genotyping method for methylenetetrahydrofolate (C677T thermolabile variant) using heteroduplex technology. Clin. Chem. 44, 2360-2362.
11. Clarke R, Naughten E, Cahalane S, O'Sullivan K, Mathias P, McCall T & Graham I (1992): The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinaemia. Irish J. Med. Sci. 161, 561-564.
12. Crosby W & Houchin DN (1957): Preparing standard solutions of cyanmethaemoglobin. Blood 12, 1132-1136.
13. Donnelly JG & Pronovost C (2000): Evaluation of the Abott IMX fluorescence polarization immunoassay: comparison with high performance liquid chromatography. Ann. Clin. Biochem. 37, 194-198.
14. Halvorsen B, Brude I, Drevon CA, Nysom J, Ose L, Christianson EN & Nenseter MS (1996): Effects of homocysteine on copper ion-catalysed, azo-compound initiated, and mononuclear cell-mediated modification of low density lipoprotein. J. Lipid Res. 37, 1591-1600.
15. Hirano K, Ogihara T, Miki M, Yasuda H, Tamai H, Kawamura N & Mino M (1994): Homocysteine induces iron-catalysed peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol. Free Rad. Res. 21, 267-276.
16. Homocysteine Lowering Trialists Collaboration (1998): Lowering blood homocysteine with folic acid supplements: meta-analysis of randomised trials. Br. Med. J. 316, 894-898.
17. Jacques P, Selhub J, Bostom AG, Wilson PWF & Rosenberg IH (1999): The effect of fortification on plasma folate and total homocysteine concentrations. New Engl. J. Med. 34, 1449-1454.
18. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR & Haynes WG (1999): Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inaemia in humans. Circulation 100, 1161-1168.
19. Lang D, Kredan M, Moat SJ, Hussain SA, Powell CA, Bellamy MF, Powers HJ & Lewis MJ (2000): Homocysteine-induced inhibition of endothelium-dependent relaxation in the rabbit aorta: a role for superoxide anions. Arterioscler. Thromb. Vasc. Biol. 20, 422-427.
20. Loehrer FMT, Haefelli WE, Angst CP, Browne G, Frick G & Fowler B (1996): Effect of methionine loading on 5-methyltetrahydrofolate, S-adenosylmethionine and S-adenosylhomocysteine in plasma of healthy humans. Clin. Sci. 91, 79-86.
21. Marklund S & Marklund G (1974): The involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469-474.
22. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V & Milner A (1993): A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. 84, 407-412.
23. Moat SJ, Bonham JR, Tanner MS, Allen JC & Powers HJ (1999): Recommended approaches for the laboratory diagnosis and monitoring of patients with hyperhomocysteinaemia. Ann. Clin. Biochem. 36, 372-379.
24. Moat SJ, Bonham JR, Cragg RA & Powers HJ (2000): Elevated plasma homocysteine elicits an increase in antioxidant enzme activity. Free Rad. Res. 33, 171-179.
25. Moat SJ, Bonham JR & Powers HJ (2001): The role of plasma aminothiols as a component of the plasma antioxidant defence system and its relevance to homocysteine-mediated vascular disease. Clin. Sci. 100, 73-79.
26. Mudd SH, Levy HL & Skovby F (1995): Disorders of Transsulphuration. The Metabolic and Molecular Basis of Inherited Disease, 7th ed., ed. CR Scriver pp 1279-1327 New York: McGraw-Hill.
27. Nakano E (2000): The effect of homocysteine on the oxidation of low density lipoproteins. Medical Science Thesis, University of Sheffield.
28. Nakano E, Higgins JA & Powers HJ (2002): Folate protects against oxidative modification of human low density lipoproteins. Br. J. Nutr. (in press).
29. Nielson F, Mikkelsen BB, Nielson JB, Andersen HR & Grandjean P (1997): Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin. Chem. 43, 1209-1214.
30. Paglia DE & Valentine WN (1967): Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70, 158-169.
31. Pullin CH, Ashfield-Watt PAL, Burr ML, Clark ZE, Lewis MJ, Moat SJ, Newcombe RG, Powers HJ, Whiting JM & McDowell IFW (2001): Optimisation of dietary folate or low dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults irrespective of methylene tetrahydrofolate reductase (C677T) genotype. J. Am. Coll. Cardiol. 38, 1799-1805.
32. Starkebaum G & Harlan JM ((1986)): Endolethial cell injury due to copper-catalysed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77, 1370-1376.
33. Thurnham DI, Smith E & Flora PS (1988): Concurrent liquid chromatographic assay of retinol, tocopherol, carotene, lycopene and crytoxanthine in plasma with tocopherol acetates as internal standard. Clin. Chem. 34, 377-381.
34. Todesco L, Angst C, Litynski P, Loehrer F, Fowler B & Haefeli WE (1999): Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age. Eur. J. Clin. Invest. 29, 1003-1009.
35. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S & Imaizumi T (1999): Endothelial dysfunction by acute hyperhomocysteinaemia: restoration by folic acid. Clin. Sci. 96, 235-239.
36. Verhaar MC, Wever RMF, Kastelein JJP, van Dam T, Koomans HA & Rabelink TJ (1998): 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolaemia. Circulation 97, 237-241.
37. Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok, FJ, Hennekens, CH & Willett WC (1996): Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12 and folate. Amer. J. Epidemiol. 143, 845-859.
38. Voutilainen S, Morrow JD, Roberts LJ, Alfthan G, Alo H, Nyyssonen K & Salonen JT (1999): Enhanced in vivo lipid peroxidation in association with elevated plasma homocysteine levels. Arterioscler. Thromb. Vasc. Biol. 19, 1263-1266.
39. Vuilleumier JP & Keck E (1989): Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment. Micron. Anal. 5, 25-34.
40. Wang XL, Adachi T, Sim AS & Wilcken DEL (1998): Plasma extracellular dismutase levels in an Australian population with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18, 1915-1921.
41. Wayner DDM, Burton GW, Ingold KU, Barclay LRC & Locke SJ (1987): The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochem. Biophys. Acta 924, 408-419.
42. Wilcken DE, Wang XL, Adachi T, Hara H, Duarte N, Green K & Wilcken B (2000): Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk. Arterioscler. Thromb. Vas. Biol. 20, 1199-1202.
43. Wilmink HW, Stroes ESG, Erkelens WD, Gerritsen WB, Wever R, Banga J-D & Rabelink TJ (2000): Influence of folic acid on postprandial endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol.